Health Catalyst, Inc. HCAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 272.21M | 292.25M | 302.48M | 311.14M | 316.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 272.21M | 292.25M | 302.48M | 311.14M | 316.06M |
| Cost of Revenue | 137.45M | 142.72M | 149.90M | 156.50M | 165.96M |
| Gross Profit | 134.76M | 149.52M | 152.58M | 154.63M | 150.11M |
| SG&A Expenses | 77.33M | 82.32M | 94.31M | 99.32M | 102.33M |
| Depreciation & Amortization | 45.70M | 48.59M | 50.30M | 50.50M | 47.88M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 298.95M | 313.62M | 336.91M | 352.41M | 367.30M |
| Operating Income | -26.75M | -21.37M | -34.44M | -41.27M | -51.23M |
| Income Before Tax | -201.38M | -263.67M | -264.34M | -177.26M | -106.66M |
| Income Tax Expenses | 715.00K | 1.15M | 915.00K | 716.00K | 962.00K |
| Earnings from Continuing Operations | -202.09 | -264.82 | -265.26 | -177.97 | -107.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -202.09M | -264.82M | -265.26M | -177.97M | -107.62M |
| EBIT | -26.75M | -21.37M | -34.44M | -41.27M | -51.23M |
| EBITDA | 5.76M | 13.92M | 2.76M | -3.27M | -14.95M |
| EPS Basic | -2.82 | -3.68 | -3.72 | -2.53 | -1.58 |
| Normalized Basic EPS | -0.34 | -0.34 | -0.46 | -0.52 | -0.61 |
| EPS Diluted | -2.83 | -3.68 | -3.72 | -2.54 | -1.59 |
| Normalized Diluted EPS | -0.34 | -0.34 | -0.46 | -0.52 | -0.61 |
| Average Basic Shares Outstanding | 292.94M | 287.93M | 283.59M | 279.55M | 270.93M |
| Average Diluted Shares Outstanding | 293.48M | 287.93M | 283.59M | 279.55M | 270.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |